Stock Events

Stock Events

Filana Therapeutics 

$1.38
345
-$0.03-2.13% Tuesday 19:55

Statistics

Day High
1.44
Day Low
1.36
52W High
4.64
52W Low
1.38
Volume
602,401
Avg. Volume
-
Mkt Cap
66.67M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Dec 12
$5.25
Dec 10
$14
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

6MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.92
-0.69
-0.45
-0.22
Expected EPS
-0.23
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-136.27MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SAVA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap27.62B
Biogen is a leading competitor in the Alzheimer's treatment market, directly competing with Cassava's simufilam.
Lilly(Eli) &
LLY
Mkt Cap862.01B
Eli Lilly has developed donanemab, an Alzheimer's disease treatment, competing in the same space as Cassava Sciences.
Pfizer
PFE
Mkt Cap149.77B
Pfizer has a history of developing treatments for neurological disorders, including Alzheimer's, making it a competitor.
AC Immune SA
ACIU
Mkt Cap303.29M
AC Immune SA focuses on developing treatments for neurodegenerative diseases, including Alzheimer's, directly competing with Cassava.
Annovis Bio
ANVS
Mkt Cap78.99M
Annovis Bio operates in the Alzheimer's and Parkinson's disease space, making it a competitor to Cassava Sciences.
Anavex Life Sciences
AVXL
Mkt Cap307.67M
Anavex Life Sciences Corp. is working on treatments for Alzheimer's disease, competing in the same market as Cassava.

About

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.
Show more...
CEO
Mr. Richard Jon Barry
Employees
30
Country
United States
ISIN
US14817C1071

Listings

MX
MX
FLNA.MX
STU
DE
PX91.STU
MU
DE
PX91.MU
XNAS
US
SAVA

0 Comments

Share your thoughts

FAQ

What is Filana Therapeutics stock price today?▼
The current price of SAVA is $1.38 USD — it has decreased by -2.13% in the past 24 hours. Watch Filana Therapeutics stock price performance more closely on the chart.
What is Filana Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Filana Therapeutics stocks are traded under the ticker SAVA.
Is Filana Therapeutics stock price growing?▼
SAVA stock has fallen by -4.17% compared to the previous week, the month change is a -42.02% fall, over the last year Filana Therapeutics has showed a -8.61% decrease.
What is Filana Therapeutics market cap?▼
Today Filana Therapeutics has the market capitalization of 66.67M
What is Filana Therapeutics revenue for the last year?▼
Filana Therapeutics revenue for the last year amounts to 0 USD.
What is Filana Therapeutics net income for the last year?▼
SAVA net income for the last year is -136.27M USD.
Does Filana Therapeutics pay dividends?▼
Yes, SAVA dividends are paid en. The last dividend per share was 5.25 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Filana Therapeutics have?▼
As of May 06, 2026, the company has 30 employees.
In which sector is Filana Therapeutics located?▼
Filana Therapeutics operates in the Health & Wellness sector.
When did Filana Therapeutics complete a stock split?▼
The last stock split for Filana Therapeutics was on December 21, 2023 with a ratio of 14:10.
Where is Filana Therapeutics headquartered?▼
Filana Therapeutics is headquartered in Austin, United States.